Ventilator-associated pneumonia caused by high risk microorganisms: A matched case-control study

Tuberkuloz ve Toraks

Volumn 56, Issue 2, 2008, Pages 139-149

  Aybar Türkoǧlu, Melda ^a,c   Topeli Iskit, Arzu ^b  

^a GAZI UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

High risk microorganisms; Length of stay; Mechanical ventilation; Mortality; Nosocomial; Outcome; Pneumonia

Indexed keywords

ACINETOBACTER; ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROORGANISM; MORTALITY; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; APACHE; CASE-CONTROL STUDIES; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA, BACTERIAL; RESPIRATION, ARTIFICIAL; TIME FACTORS;

EID: 47749113714     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21: 510-5.
2. Urli T, Perone A, Acquarolo S, et al. Surveillance of infections acquired in intensive care: Usefulness in clinical practice. J Hosp Infect 2002; 52: 130-5.
3. Legras A, Malvy D, Quinioux AI, et al. Nosocomial infections: Prospective survey of incidence in five French intensive care units. Intensive Care Med 1998; 24: 1040-6.
4. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94: 281-8.
5. Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996; 154: 91-7.
6. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortalitiy of ventilator associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999; 159: 1249-56.
7. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: A prospective case-control study. Crit Care Med 2001; 29: 2303-9.
8. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argantina: Attributable mortality and length of stay. Am J Infect Control 2003; 31: 291-5.
9. Hanes SD, Demirkan K, Tolley E, et al. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis 2002; 35: 228-35.
10. Nicholson AM, Castle D, Akpaka P, et al. The emergence of Stenotrophomonas maltophilia as a significant nosocomial pathogen at the University Hospital of the West Indies. West Indian Med J 2004; 53: 17-22.
11. Torres A, Carlet J (European Task Force on ventilator-associated pneumonia). Ventilator-associated pneumonia. Eur Respir J 2001; 17: 1034-45.
12. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129: 1210-8.
13. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150(6 Pt 1): 1545-9.
14. Jimenez P, Torres A, Rodriguez-Roisin R, et al. Incidence and aetiology of pneumonia acquired during mechanical ventilation. Crit Care Med 1989; 17: 882-5.
15. Rello J, Ollendorf DA, Oster G, et al. VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122: 2115-21.
16. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003; 31: 1312-7.
17. Shorr AF, Combes A, Kollef MH, Chastre J. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med 2006; 34: 700-6.
18. Garnacho J, Sole-Violan J, Sa-Borges M, et al. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: A matched cohort study. Crit Care Med 2003; 31: 2478-82.
19. Garnacho-Montero J, Ortiz-Leyha C, Fernández-Hinojosa E, et al. Acinetobacter baumannii ventilator-associated pneumonia: Epidemiological and clinical findings. Intensive Care Med 2005; 31: 649-55.
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-29.
21. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 13: 81-4.
22. Grossman RF, Fein A. Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia: Executive summary. Chest 2000; 117 (Suppl 2): 117-81.
23. El-Ebiary M, Torres A, González J, et al. Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis 1993; 148(6 Pt 1): 1552-7.
24. Tega L, Raieta K, Ottaviani D, et al. Catheter-related bacteremia and multidrug-resistant Acinetobacter lwoffii. Emerg Infect Dis 2007; 13: 355-6.
25. Ku SC, Hsueh PR, Yang PC, et al. Clinical and microbiological characteristics of bacteremia caused by Acinetobacter lwoffii. Eur J Clin Microbiol Infect Dis 2000; 19: 501-5.
26. Domingo P, Muñoz R, Frontera G, et al. Community-acquired pneumonia due to Acinetobacter lwoffii in a patient infected with the human immunodeficiency virus. Clin Infect Dis 1995; 20: 205-6.
27. Bregeon F, Ciais V, Carret V, et al. Is ventilator-associated pneumonia an independent risk factor for death? Anesthesiology 2001; 94: 554-60.
28. Rello J, Juber P, Vallés J, et al. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 1996; 23: 973-978.
29. Blot S, Vandewoude K, Hoste E, Colardyn F. Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa. J Hosp Infect 2003; 53: 18-24.
30. Gonzáles C, Rubio M, Romero-Vivas J, et al. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29: 1171-7.
31. Knaus WA. Prognosis with mechanical ventilation: The influence of disease, severity of disease, age and chronic health status on survival from an acute illness. Am Rev Respir Dis 1989; 140: 8-13.